217 related articles for article (PubMed ID: 12620069)
1. Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
Wei ZL; Petukhov PA; Xiao Y; Tückmantel W; George C; Kellar KJ; Kozikowski AP
J Med Chem; 2003 Mar; 46(6):921-4. PubMed ID: 12620069
[TBL] [Abstract][Full Text] [Related]
2. Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
Huang Y; Zhu Z; Xiao Y; Laruelle M
Bioorg Med Chem Lett; 2005 Oct; 15(19):4385-8. PubMed ID: 16039849
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors.
Wei ZL; Xiao Y; Kellar KJ; Kozikowski AP
Bioorg Med Chem Lett; 2004 Apr; 14(8):1855-8. PubMed ID: 15050615
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine.
Carroll FI; Robinson TP; Brieaddy LE; Atkinson RN; Mascarella SW; Damaj MI; Martin BR; Navarro HA
J Med Chem; 2007 Dec; 50(25):6383-91. PubMed ID: 17994682
[TBL] [Abstract][Full Text] [Related]
5. Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
Wei ZL; Xiao Y; Yuan H; Baydyuk M; Petukhov PA; Musachio JL; Kellar KJ; Kozikowski AP
J Med Chem; 2005 Mar; 48(6):1721-4. PubMed ID: 15771418
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity data of some new epibatidine analogues.
Seerden JP; Tulp MT; Scheeren HW; Kruse CG
Bioorg Med Chem; 1998 Nov; 6(11):2103-10. PubMed ID: 9881100
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
Carroll FI; Lee JR; Navarro HA; Ma W; Brieaddy LE; Abraham P; Damaj MI; Martin BR
J Med Chem; 2002 Oct; 45(21):4755-61. PubMed ID: 12361403
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist.
Carroll FI; Lee JR; Navarro HA; Brieaddy LE; Abraham P; Damaj MI; Martin BR
J Med Chem; 2001 Nov; 44(24):4039-41. PubMed ID: 11708907
[TBL] [Abstract][Full Text] [Related]
9. Epibatidine structure-activity relationships.
Carroll FI
Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptors.
Mu L; Drandarov K; Bisson WH; Schibig A; Wirz C; Schubiger PA; Westera G
Eur J Med Chem; 2006 May; 41(5):640-50. PubMed ID: 16545497
[TBL] [Abstract][Full Text] [Related]
11. 3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor.
Gohlke H; Schwarz S; Gündisch D; Tilotta MC; Weber A; Wegge T; Seitz G
J Med Chem; 2003 May; 46(11):2031-48. PubMed ID: 12747776
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.
Gohlke H; Gündisch D; Schwarz S; Seitz G; Tilotta MC; Wegge T
J Med Chem; 2002 Feb; 45(5):1064-72. PubMed ID: 11855986
[TBL] [Abstract][Full Text] [Related]
13. Functionalization of the alicyclic skeleton of epibatidine: synthesis and nicotinic acetylcholine receptor binding affinities of epibatidine analogues.
Wei ZL; Xiao Y; George C; Kellar KJ; Kozikowski AP
Org Biomol Chem; 2003 Nov; 1(22):3878-81. PubMed ID: 14664377
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analogues.
Carroll FI; Brieaddy LE; Navarro HA; Damaj MI; Martin BR
J Med Chem; 2005 Nov; 48(23):7491-5. PubMed ID: 16279810
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.
Carroll FI; Ma W; Yokota Y; Lee JR; Brieaddy LE; Navarro HA; Damaj MI; Martin BR
J Med Chem; 2005 Feb; 48(4):1221-8. PubMed ID: 15715488
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues.
Carroll FI; Liang F; Navarro HA; Brieaddy LE; Abraham P; Damaj MI; Martin BR
J Med Chem; 2001 Jun; 44(13):2229-37. PubMed ID: 11405659
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists.
Carroll FI; Ma W; Deng L; Navarro HA; Damaj MI; Martin BR
J Nat Prod; 2010 Mar; 73(3):306-12. PubMed ID: 20038125
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and binding affinity at α4β2 and α7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring system.
Dallanoce C; Matera C; Pucci L; Gotti C; Clementi F; Amici MD; Micheli CD
Bioorg Med Chem Lett; 2012 Jan; 22(2):829-32. PubMed ID: 22222032
[TBL] [Abstract][Full Text] [Related]
19. Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.
Bisson WH; Scapozza L; Westera G; Mu L; Schubiger PA
J Med Chem; 2005 Aug; 48(16):5123-30. PubMed ID: 16078832
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
Sharples CG; Karig G; Simpson GL; Spencer JA; Wright E; Millar NS; Wonnacott S; Gallagher T
J Med Chem; 2002 Jul; 45(15):3235-45. PubMed ID: 12109907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
